Siliconangle2026-10-23 20:02:03

AI drug development startup Pathos AI closes $237M investment

Pathos AI Inc. today announced that it has raised $237 million in funding at a $3 billion valuation.

Summary

Pharmaceutical giant Bristol Myers Squibb Co. led the Series E round with participation from several unnamed returning backers. Pathos’ investor roster includes big names such as AstraZeneca plc, NEA and General Atlantic.

newsbristol-myers squibbdrug developmentventure capitalstartupaipathos aifunding round

This is a brief wire summary, the full story (linked below) has the complete details.

KazaSec's take

AI-related security incidents are a genuinely new category, prompt injection, model manipulation, and data leakage through an LLM integration don't map cleanly onto traditional application security testing, and are worth assessing deliberately rather than assuming existing controls already cover them.

Coverage details

Source: Siliconangle
Published: 2026-10-23 20:02:03
Author: maria deutscher
Category: technology

We've archived 1006 other articles touching the same topic (news, bristol-myers squibb, drug development) , see the full security news archive.

Worried this kind of story could be about you next?

We help organizations find and fix the gaps before they make headlines.

Request a Security Assessment Browse Services